top of page

Ophthalmic Strategic Consulting


EyeQ Research is the Leading Consulting Partner for Strategic Transactions in Eye Care

What We Do


EyeQ Research provides consulting services to innovators and investors in eye care: Financial modeling and business valuation, proprietary market research, due diligence, and strategic advisory.

Our services support a variety of strategic transactions: M&A, fundraising activities, investment decisions, and business development initiatives.

Our clients include company boards and management teams, institutional investors, and strategic acquirers.

We work across multiple device and pharmaceutical market segments in eye care, including cataract and refractive surgery, glaucoma, retina, cornea, and vision care.

About Us


Michael E. Lachman brings 30 years of experience in medical technology, including consulting, investment research, business development, marketing, and engineering. His active involvement in the ophthalmology sector spans over 20 years.

OIS Logo.jpg
Eyecelerator Logo JPEG 2.jpg

Success Stories


Since 2005, EyeQ Research has completed projects for over 80 clients in eye care and other healthcare markets. A majority of these client relationships have grown into multi-project engagements.

We have provided services to clients in support of a wide range of strategic transactions, including:

  • AcuFocus in its acquisition by Bausch + Lomb

  • Tear Film Innovations and WaveTec Vision in their acquisitions by Alcon

  • ianTECH in its acquisition by Carl Zeiss Meditec

  • Avedro in its initial public offering

  • TearScience in its acquisition by Johnson & Johnson Vision

  • SightLife in the establishment of CorneaGen

ianTECH Logo from Web Site 2.jpg
TearScience logo.jpg

Contact Us


Our offices are located in the San Francisco Bay Area. Please contact us via phone or e-mail to request more information about our services.


Phone: (925) 876-1257



Press & Media

Our coverage of important developments in the ophthalmic market is featured in leading industry publications and media outlets.
Ophthalmic Stock Performance: ASCRS 2022
April 2022
Myopia Control Products & Companies: AAO 2021
November 2021
Video: 2020 Virtual Lecture Series: Innovative Partnerships in Presbyopia - with Panel Discussion
December 2020
EyeQ Research partnered with Ophthalmology Innovation Summit to create the OIS Index, a composite of ophthalmic growth stocks tracking investment performance of the industry.
Video: OIS Index 6-Month Review at OIS Public Company Showcase
July 2020

Success! Message received.

bottom of page